ResearchMoz

Drug Delivery Devices Market Outlook in South Africa to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Publisher Name » GlobalData
Published Date » 2011-05-19
No. Of Pages » 112


GlobalDatas new report, Drug Delivery Devices Market Outlook in South Africa to 2017 Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections provides key market data on the South Africa Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Market size and company share data for Drug Delivery Devices market categories Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017. 
  • 2010 company shares and distribution shares data for each of the four market categories.
  • Global corporate-level profiles of key companies operating within the South Africa Drug Delivery Devices market. 
  • Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Cipla Medpro (Pty) Ltd., Boehringer Ingelheim GmbH, Fresenius Kabi AG, Hospira, Inc. and others.
Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the South Africa Drug Delivery Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction 11
2.1 What is This Report About? 11
3 Drug Delivery Devices In South Africa 12
3.1 Drug Delivery Devices, Market Segmentation 12
3.2 Drug Delivery Devices, South Africa, Overall Revenue ($m), 2003-2017 13
3.3 Drug Delivery Devices Market, South Africa, Revenue Mix ($m), 2010 15
3.4 Drug Delivery Devices Market, South Africa, Category Contribution (%), 2010 16
3.5 Drug Delivery Devices, South Africa, Category Volume (Units), 2003-2017 22
3.6 Drug Delivery Devices, South Africa, Company Share (2009-2010) 27
4 Central Venous Catheters In South Africa 29
4.1 Central Venous Catheters, Market Segmentation 29
4.2 Central Venous Catheters Market, South Africa, Revenue Mix ($m), 2010 30
4.3 Central Venous Catheters Market, South Africa, Segment Contribution (%), 2010 31
4.4 Central Venous Catheters Overall Revenue (2003-2017) 32
4.5 Central Venous Catheters Overall Volume (2003-2017) 36
4.6 Central Venous Catheters Average Price (2003-2017) 40
4.7 Central Venous Catheters Distribution Share (2009-2010) 41
4.8 Central Venous Catheters, South Africa, Company Share (2009-2010) 42

5 Infusion Systems In South Africa 44
5.1 Infusion Systems, Market Segmentation 44
5.2 Infusion Systems Market, South Africa, Revenue Mix ($m), 2010 45
5.3 Infusion Systems Market, South Africa, Segment Contribution (%), 2010 46
5.4 Infusion Systems Overall Revenue (2003-2017) 47
5.4.1 Syringe Pumps Revenue (2003-2017) 51
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 55
5.5 Infusion Systems Overall Volume (2003-2017) 59
5.5.1 Syringe Pumps Volume (2003-2017) 63
5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 66
5.6 Infusion Systems Average Price (2003-2017) 70
5.7 Infusion Systems Distribution Share (2009-2010) 71
5.8 Infusion Systems, South Africa, Company Share (2009-2010) 72

6 Metered Dose Inhaler Devices In South Africa 74
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 74
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 76
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 78
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 79
6.5 Metered Dose Inhaler Devices, South Africa, Company Share (2009-2010) 80

7 Needle Free Injections In South Africa 82
7.1 Needle Free Injections Overall Revenue (2003-2017) 82
7.2 Needle Free Injections Overall Volume (2003-2017) 84
7.3 Needle Free Injections Average Price (2003-2017) 86
7.4 Needle Free Injections Distribution Share (2009-2010) 87
7.5 Needle Free Injections, South Africa, Company Share (2009-2010) 88

8 Overview of Key Companies in South Africa Drug Delivery Devices Market 89
8.1 GlaxoSmithKline plc 89
8.1.1 Company Overview 89
8.1.2 Share in the South Africa Drug Delivery Devices Market 89
8.2 AstraZeneca PLC 90
8.2.1 Company Overview 90
8.2.2 Share in the South Africa Drug Delivery Devices Market 90
8.3 Cipla Medpro (Pty) Ltd. 91
8.3.1 Company Overview 91
8.3.2 Share in the South Africa Drug Delivery Devices Market 91
8.4 Boehringer Ingelheim GmbH 92
8.4.1 Company Overview 92
8.4.2 Share in the South Africa Drug Delivery Devices Market 92
8.5 Fresenius Kabi AG 93
8.5.1 Company Overview 93
8.5.2 Share in the South Africa Drug Delivery Devices Market 93
8.6 Hospira, Inc. 94
8.6.1 Company Overview 94
8.6.2 Share in the South Africa Drug Delivery Devices Market 94
8.7 Medtronic, Inc. 95
8.7.1 Company Overview 95
8.8 B. Braun Melsungen AG 95
8.8.1 Company Overview 95
8.9 Baxter International Inc. 95
8.9.1 Company Overview 95
8.10 CareFusion Corporation 96
8.10.1 Company Overview 96
8.11 Smiths Medical 96
8.11.1 Company Overview 96
8.12 Terumo Corporation 96
8.12.1 Company Overview 96
8.13 3M Health Care 97
8.13.1 Company Overview 97
8.14 NIPRO CORPORATION 97
8.14.1 Company Overview 97
8.15 Arcomed A.G. Medical Systems 97
8.15.1 Company Overview 97
8.16 Consort Medical plc 98
8.16.1 Company Overview 98
8.17 JMS CO., LTD. 98
8.17.1 Company Overview 98
8.18 INJEX - Equidyne Systems 98
8.18.1 Company Overview 98
8.19 Edwards Lifesciences Corporation 99
8.19.1 Company Overview 99
8.20 Teleflex Incorporated 99
8.20.1 Company Overview 99
8.21 Becton, Dickinson and Company 100
8.21.1 Company Overview 100
8.22 Cook Medical Incorporated 100
8.22.1 Company Overview 100
8.23 Bioject Medical Technologies Inc. 100
8.23.1 Company Overview 100

9 Drug Delivery Devices Market Pipeline Products 101

10 Appendix 105
10.1 Definitions of Markets Covered in the Report 106
10.1.1 Drug Delivery Devices 106
10.2 Research Methodology 109
10.3 Secondary Research 109
10.4 Primary Research 110
10.5 Models 110
10.6 Forecasts 111
10.7 Expert Panels 111
10.8 GlobalData Consulting 111
10.9 Currency Conversion 111
10.10 Contact Us 112
10.11 Disclaimer 112

List of Tables


Table 1: Drug Delivery Devices, South Africa, Overall Revenue ($m), 2003-2017 14
Table 2: Drug Delivery Devices Market, South Africa, Category Contribution (%), 2010 16
Table 3: Drug Delivery Devices, South Africa Cross-Category Analysis, 2003-2017 17
Table 4: Drug Delivery Devices, South Africa, Overall Revenue ($m), Historic, 2003-2010 19
Table 5: Drug Delivery Devices, South Africa, Overall Revenue ($m), Forecast, 2010-2017 21
Table 6: Drug Delivery Devices, South Africa, Category Volume (Units), 2003-2017 22
Table 7: Drug Delivery Devices, South Africa, Category Volume (Units), Historic, 2003-2010 24
Table 8: Drug Delivery Devices, South Africa, Category Volume (Units), Forecast, 2010-2017 26
Table 9: Drug Delivery Devices, South Africa, Company Share by Revenue ($m), 2009-2010 28
Table 10: Central Venous Catheters Market, South Africa, Segment Contribution (%), 2010 31
Table 11: Central Venous Catheters, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 33
Table 12: Central Venous Catheters, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 35
Table 13: Central Venous Catheters, South Africa, Volume (Units) by Segment, Historic, 2003-2010 37
Table 14: Central Venous Catheters, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 39
Table 15: Central Venous Catheters, South Africa, Average Price ($), Historic, 2003-2010 40
Table 16: Central Venous Catheters, South Africa, Average Price ($), Forecast, 2010-2017 40
Table 17: Central Venous Catheters, South Africa, Distribution Share by Revenue ($m), 2009-2010 41
Table 18: Central Venous Catheters, South Africa, Company Share by Revenue ($m), 2009-2010 43
Table 19: Infusion Systems Market, South Africa, Segment Contribution (%), 2010 46
Table 20: Infusion Systems, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 48
Table 21: Infusion Systems, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 50
Table 22: Syringe Pumps, South Africa, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52
Table 23: Syringe Pumps, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54
Table 24: Ambulatory Infusion Pumps, South Africa, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Table 25: Ambulatory Infusion Pumps, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Table 26: Infusion Systems, South Africa, Volume (Units) by Segment, Historic, 2003-2010 60
Table 27: Infusion Systems, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 62
Table 28: Syringe Pumps, South Africa, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Table 29: Syringe Pumps, South Africa, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Table 30: Ambulatory Infusion Pumps, South Africa, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Table 31: Ambulatory Infusion Pumps, South Africa, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Table 32: Infusion Systems, South Africa, Average Price ($), Historic, 2003-2010 70
Table 33: Infusion Systems, South Africa, Average Price ($), Forecast, 2010-2017 70
Table 34: Infusion Systems, South Africa, Distribution Share by Revenue ($m), 2009-2010 71
Table 35: Infusion Systems, South Africa, Company Share by Revenue ($m), 2009-2010 73
Table 36: Metered Dose Inhaler Devices, South Africa, Revenue ($m), Historic, 2003-2010 74
Table 37: Metered Dose Inhaler Devices, South Africa, Revenue ($m), Forecast, 2010-2017 75
Table 38: Metered Dose Inhaler Devices, South Africa, Volume (Units), Historic, 2003-2010 76
Table 39: Metered Dose Inhaler Devices, South Africa, Volume (Units), Forecast, 2010-2017 77
Table 40: Metered Dose Inhaler Devices, South Africa, Average Price ($), Historic, 2003-2010 78
Table 41: Metered Dose Inhaler Devices, South Africa, Average Price ($), Forecast, 2010-2017 78
Table 42: Metered Dose Inhaler Devices, South Africa, Distribution Share by Revenue ($m), 2009-2010 79
Table 43: Metered Dose Inhaler Devices, South Africa, Company Share by Revenue ($m), 2009-2010 81
Table 44: Needle Free Injections, South Africa, Revenue ($m), Historic, 2003-2010 82
Table 45: Needle Free Injections, South Africa, Revenue ($m), Forecast, 2010-2017 83
Table 46: Needle Free Injections, South Africa, Volume (Units), Historic, 2003-2010 84
Table 47: Needle Free Injections, South Africa, Volume (Units), Forecast, 2010-2017 85
Table 48: Needle Free Injections, South Africa, Average Price ($), Historic, 2003-2010 86
Table 49: Needle Free Injections, South Africa, Average Price ($), Forecast, 2010-2017 86
Table 50: Needle Free Injections, South Africa, Distribution Share by Revenue ($m), 2009-2010 87
Table 51: Needle Free Injections, South Africa, Company Share by Revenue ($m), 2009-2010 88
Table 52: Drug Delivery Devices Market Pipeline Products 101
Table 53: USD to Local Currency, South Africa, Average Actual Rate 2003-2010 111

List of Figures


Figure 1: Drug Delivery Devices, Market Segmentation 12
Figure 2: Drug Delivery Devices, South Africa, Overall Revenue ($m), 2003-2017 13
Figure 3: Drug Delivery Devices Market, South Africa, Revenue Mix ($m), 2010 15
Figure 4: Drug Delivery Devices Market, South Africa, Category Contribution (%), 2010 16
Figure 5: Drug Delivery Devices Market, South Africa, Cross-Category Analysis, 2003-2017 17
Figure 6: Drug Delivery Devices, South Africa, Overall Revenue ($m), Historic, 2003-2010 18
Figure 7: Drug Delivery Devices, South Africa, Overall Revenue ($m), Forecast, 2010-2017 20
Figure 8: Drug Delivery Devices, South Africa, Category Volume (Units), 2003-2017 22
Figure 9: Drug Delivery Devices, South Africa, Category Volume (Units), Historic, 2003-2010 23
Figure 10: Drug Delivery Devices, South Africa, Category Volume (Units), Forecast, 2010-2017 25
Figure 11: Drug Delivery Devices, South Africa, Company Share (%), 2010 27
Figure 12: Central Venous Catheters, Market Segmentation 29
Figure 13: Central Venous Catheters Market, South Africa, Revenue Mix ($m), 2010 30
Figure 14: Central Venous Catheters Market, South Africa, Segment Contribution (%), 2010 31
Figure 15: Central Venous Catheters, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 32
Figure 16: Central Venous Catheters, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 34
Figure 17: Central Venous Catheters, South Africa, Volume (Units) by Segment, Historic, 2003-2010 36
Figure 18: Central Venous Catheters, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 38
Figure 19: Central Venous Catheters, South Africa, Company Share (%), 2010 42
Figure 20: Infusion Systems, Market Segmentation 44
Figure 21: Infusion Systems Market, South Africa, Revenue Mix ($m), 2010 45
Figure 22: Infusion Systems Market, South Africa, Segment Contribution (%), 2010 46
Figure 23: Infusion Systems, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 47
Figure 24: Infusion Systems, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 49
Figure 25: Syringe Pumps, South Africa, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51
Figure 26: Syringe Pumps, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53
Figure 27: Ambulatory Infusion Pumps, South Africa, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55
Figure 28: Ambulatory Infusion Pumps, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57
Figure 29: Infusion Systems, South Africa, Volume (Units) by Segment, Historic, 2003-2010 59
Figure 30: Infusion Systems, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 61
Figure 31: Syringe Pumps, South Africa, Volume (Units) by Sub-Segment, Historic, 2003-2010 63
Figure 32: Syringe Pumps, South Africa, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Figure 33: Ambulatory Infusion Pumps, South Africa, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Figure 34: Ambulatory Infusion Pumps, South Africa, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 35: Infusion Systems, South Africa, Company Share (%), 2010 72
Figure 36: Metered Dose Inhaler Devices, South Africa, Revenue ($m), Historic, 2003-2010 74
Figure 37: Metered Dose Inhaler Devices, South Africa, Revenue ($m), Forecast, 2010-2017 75
Figure 38: Metered Dose Inhaler Devices, South Africa, Volume (Units), Historic, 2003-2010 76
Figure 39: Metered Dose Inhaler Devices, South Africa, Volume (Units), Forecast, 2010-2017 77
Figure 40: Metered Dose Inhaler Devices, South Africa, Company Share (%), 2010 80
Figure 41: Needle Free Injections, South Africa, Revenue ($m), Historic, 2003-2010 82
Figure 42: Needle Free Injections, South Africa, Revenue ($m), Forecast, 2010-2017 83
Figure 43: Needle Free Injections, South Africa, Volume (Units), Historic, 2003-2010 84
Figure 44: Needle Free Injections, South Africa, Volume (Units), Forecast, 2010-2017 85
Figure 45: Needle Free Injections, South Africa, Company Share (%), 2010 88
Figure 46: GlaxoSmithKline plc, Company Share (%),South Africa Drug Delivery Devices Market, 2010 89
Figure 47: AstraZeneca PLC, Company Share (%),South Africa Drug Delivery Devices Market, 2010 90
Figure 48: Cipla Medpro (Pty) Ltd., Company Share (%),South Africa Drug Delivery Devices Market, 2010 91
Figure 49: Boehringer Ingelheim GmbH, Company Share (%),South Africa Drug Delivery Devices Market, 2010 92
Figure 50: Fresenius Kabi AG, Company Share (%),South Africa Drug Delivery Devices Market, 2010 93
Figure 51: Hospira, Inc., Company Share (%),South Africa Drug Delivery Devices Market, 2010 94

Upcoming Reports:

Healthcare Biometrics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Biometrics is the process of identification through the utilization of unique bodily functions such as DNA, finger prints and facial traits. The main function of such a system is to apprehend security threats. The healthcare biometrics market deals with the integration of the biometric process into the healthcare sector. The global healthcare biometrics market is expected to grow at a CAGR of 33% from 2012 to 2018, and it is expected to reach an estimated figure of USD 1,005.015 million by the year 2018. The U.S holds the maximum market share for the healthcare biometrics...
Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, immature blood cells are present in the bone marrow. Symptoms found in patients due to the disease are flu, loss of weight, body ache and pain and spots on skin.  The Acute Myeloid Leukemia (AML) therapeutics market was USD 239.3 million in 2011 and this market is forecasted to...
Connected Car Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Growing need for connectivity and changing consumer preferences are some of the major factors fueling the growth of the connected car market. A connected car is equipped with internet access and with a wireless local area network. This facilitates the car to share this access with other devices, both internally and externally. In the present scenario, connected cars (especially electric cars) are grabbing the opportunity to grow along with a rise in smartphones, and related applications interact with the car from any distance. The future of this market depends on the extent to...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...